196 related articles for article (PubMed ID: 19852697)
1. Long-term treatment of patients with Alzheimer's disease in primary and secondary care: results from an international survey.
Froelich L; Andreasen N; Tsolaki M; Foucher A; Kavanagh S; Baelen BV; Schwalen S
Curr Med Res Opin; 2009 Dec; 25(12):3059-68. PubMed ID: 19852697
[TBL] [Abstract][Full Text] [Related]
2. [Predictors of long-term institutionalization in patients with Alzheimer's disease: role of caregiver burden].
Hirono N; Tsukamoto N; Inoue M; Moriwaki Y; Mori E
No To Shinkei; 2002 Sep; 54(9):812-8. PubMed ID: 12428367
[TBL] [Abstract][Full Text] [Related]
3. [Caregiver burden in dementia: evaluation with a Japanese version of the Zarit caregiver burden interview].
Hirono N; Kobayashi H; Mori E
No To Shinkei; 1998 Jun; 50(6):561-7. PubMed ID: 9656252
[TBL] [Abstract][Full Text] [Related]
4. A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting.
Tariot PN; Cummings JL; Katz IR; Mintzer J; Perdomo CA; Schwam EM; Whalen E
J Am Geriatr Soc; 2001 Dec; 49(12):1590-9. PubMed ID: 11843990
[TBL] [Abstract][Full Text] [Related]
5. Effects of galantamine on behavioural and psychological disturbances and caregiver burden in patients with Alzheimer's disease.
Monsch AU; Giannakopoulos P;
Curr Med Res Opin; 2004 Jun; 20(6):931-8. PubMed ID: 15200752
[TBL] [Abstract][Full Text] [Related]
6. [Impact of music therapy on anxiety and depression for patients with Alzheimer's disease and on the burden felt by the main caregiver (feasibility study)].
Guetin S; Portet F; Picot MC; Defez C; Pose C; Blayac JP; Touchon J
Encephale; 2009 Feb; 35(1):57-65. PubMed ID: 19250995
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of open-label donepezil treatment in patients with Alzheimer's disease discontinuing memantine monotherapy.
Sakka P; Tsolaki M; Hort J; Hager K; Soininen H; López Pousa S; Li C; Schwam E
Curr Med Res Opin; 2007 Dec; 23(12):3153-65. PubMed ID: 17988434
[TBL] [Abstract][Full Text] [Related]
8. Long-term effects of rivastigmine treatment on neuropsychiatric and behavioral disturbances in nursing home residents with moderate to severe Alzheimer's disease: results of a 52-week open-label study.
Aupperle PM; Koumaras B; Chen M; Rabinowicz A; Mirski D
Curr Med Res Opin; 2004 Oct; 20(10):1605-12. PubMed ID: 15462693
[TBL] [Abstract][Full Text] [Related]
9. A large, naturalistic, community-based study of rivastigmine in mild-to-moderate AD: the EXTEND Study.
Gauthier S; Juby A; Morelli L; Rehel B; Schecter R;
Curr Med Res Opin; 2006 Nov; 22(11):2251-65. PubMed ID: 17076986
[TBL] [Abstract][Full Text] [Related]
10. Caregivers' assessments of preference-based quality of life in Alzheimer's disease.
Karlawish JH; Zbrozek A; Kinosian B; Gregory A; Ferguson A; Low DV; Glick HA
Alzheimers Dement; 2008 May; 4(3):203-11. PubMed ID: 18631969
[TBL] [Abstract][Full Text] [Related]
11. Validity and reliability of the SF-36 administered to caregivers of patients with alzheimer's disease: evidence from a south american sample.
Machnicki G; Allegri RF; Ranalli CG; Serrano CM; Dillon C; Wyrwich KW; Taragano FE
Dement Geriatr Cogn Disord; 2009; 28(3):206-12. PubMed ID: 19752555
[TBL] [Abstract][Full Text] [Related]
12. One-year longitudinal evaluation of neuropsychiatric symptoms in Alzheimer's disease. The REAL.FR Study.
Benoit M; Robert PH; Staccini P; Brocker P; Guerin O; Lechowski L; Vellas B;
J Nutr Health Aging; 2005; 9(2):95-9. PubMed ID: 15791352
[TBL] [Abstract][Full Text] [Related]
13. Assessing quality of life in Taiwanese patients with Alzheimer's disease.
Fuh JL; Wang SJ
Int J Geriatr Psychiatry; 2006 Feb; 21(2):103-7. PubMed ID: 16416471
[TBL] [Abstract][Full Text] [Related]
14. Treatment with galantamine and time to nursing home placement in Alzheimer's disease patients with and without cerebrovascular disease.
Feldman HH; Pirttila T; Dartigues JF; Everitt B; Van Baelen B; Schwalen S; Kavanagh S
Int J Geriatr Psychiatry; 2009 May; 24(5):479-88. PubMed ID: 18985627
[TBL] [Abstract][Full Text] [Related]
15. Donepezil preserves cognition and global function in patients with severe Alzheimer disease.
Black SE; Doody R; Li H; McRae T; Jambor KM; Xu Y; Sun Y; Perdomo CA; Richardson S
Neurology; 2007 Jul; 69(5):459-69. PubMed ID: 17664405
[TBL] [Abstract][Full Text] [Related]
16. Determinants of costs of care for patients with Alzheimer's disease.
Jönsson L; Eriksdotter Jönhagen M; Kilander L; Soininen H; Hallikainen M; Waldemar G; Nygaard H; Andreasen N; Winblad B; Wimo A
Int J Geriatr Psychiatry; 2006 May; 21(5):449-59. PubMed ID: 16676288
[TBL] [Abstract][Full Text] [Related]
17. The neuropsychiatric inventory scores change across the mini mental state examination ranges in patients with Alzheimer's disease: a multicenter study in Turkey.
Yener GG;
Cogn Behav Neurol; 2009 Dec; 22(4):264-9. PubMed ID: 19996880
[TBL] [Abstract][Full Text] [Related]
18. Patient and caregiver outcomes after 6 +/- 1.5-months of rivastigmine therapy for mild-to-moderate Alzheimer's disease: the Belgian FExT study.
Mets T; Vandewoude M; Jacquy J; Deblander A; MacDonald K; Sloesen A; Abraham I;
Curr Med Res Opin; 2007 Oct; 23(10):2485-501. PubMed ID: 17784995
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of a psychoeducational intervention program in the reduction of caregiver burden in Alzheimer's disease patients' caregivers.
Martín-Carrasco M; Martín MF; Valero CP; Millán PR; García CI; Montalbán SR; Vázquez AL; Piris SP; Vilanova MB
Int J Geriatr Psychiatry; 2009 May; 24(5):489-99. PubMed ID: 18949763
[TBL] [Abstract][Full Text] [Related]
20. [Profile of the informal carer associated with the clinical management of the Alzheimer's disease patient refractory to symptomatic treatment of the disease].
Molinuevo JL; Hernández B;
Neurologia; 2011 Nov; 26(9):518-27. PubMed ID: 21803459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
